五、参考文献
[1]《中国骨质疏松症流行病学调查报告2018.》
[2]特立帕肽注射液(复泰奥?)中文说明书.
[3]特立帕肽注射液(フォルテオ?皮下注キット600μg)日本IF文件.
[4]特立帕肽注射液生物类似药临床试验设计指导原则》.
[5]livogiva-epar-public-assessment-report_en.EMA
[6]FORTEO(teriparatideinjection),forsubcutaneoususe.FDAlable.
[7]movymia-epar-public-assessment-report_en
[8]sondelbay-epar-public-assessment-report_en.EMA
[9]Farías,J.,Keller,G.A.,Papouchado,M.,VillaEtchegoyen,M.C.,Criscuolo,M.E.,Diez,R.A.,&DiGirolamo,G.(2016).Relativebioavailabilitybetweentwoteriparatideformulationsinhealthyvolunteers.Internationaljournalofclinicalpharmacologyandtherapeutics,54(8),649–656.
[10]Takács,I.,Jókai,E.,Kováts,D.E.,&Aradi,I.(2019).Thefirstbiosimilarapprovedforthetreatmentofosteoporosis:resultsofacomparativepharmacokinetic/pharmacodynamicstudy.Osteoporosisinternational:ajournalestablishedasresultofcooperationbetweentheEuropeanFoundationforOsteoporosisandtheNationalOsteoporosisFoundationoftheUSA,30(3),675–683.
[11]特立帕肽注射液(CXSS2100011)申请上市技术审评报告.返回搜狐 , 查看更多
责任编辑:
- 葡萄糖注射液|岳父牙痛10年,被民间老中医治好了,只用了一个小方法……
- 不是要控糖吗?糖尿病患者需要注射液,为何医生却选择了葡萄糖?
- 为何诺西那生钠注射液国内外相差3万多倍?医生:这锅我们不背
- 鲁南制药麦洛畅阿加曲班注射液新增规格获批上市
- 特立独行,时尚、够IN!染发美甲才有范儿?小心白癜风来犯!
- 财鑫闻丨步长制药主力产品注射液再被调出医保目录,营收占比近3成